|
|
Effect analysis of Budesonide Ultrasonic Atomization combined with Azithromycin in the treatment of Mycoplasma pneumoniae infection in children |
LIAO Ji-yan1 LI Mu-lan2 ZHANG Gui-hua1 |
1.Department of Paediatrics,Maternal and Child Health Hospital in Yingde City,Guangdong Province,Yingde 513000,China;
2.Clinical Laboratory,Maternal and Child Health Hospital in Yingde City,Guangdong Province,Yingde 513000,China |
|
|
Abstract ObjectiveTo investigate the clinical efficacy of Budesonide Ultrasonic Atomization combined with Azithromycin in the treatment of Mycoplasma pneumoniae infection in children,so as to provide a reference for the rational selection of treatment options.Methods78 children with Mycoplasma pneumoniae infection treated in our hospital from February 2016 to August 2017 were selected as the objects of observation,the random number table was used to divide them into two groups,each with 39 cases.The observation group was treated with Budesonide Ultrasonic Atomization combined with Azithromycin,and the control group was treated with Azithromycin alone.Two groups of treatment were 3 weeks.The clinical efficacy and adverse reactions of the two groups were observed after 3 weeks.ResultsThe total effective rate of the observation group was 94.87%,which was significantly higher than that of the control group(74.36%),the difference was statistically significant(P<0.05).The disappeared time of wheezing breathing,fever,lung rales and cough in the observation group were significantly shorter than those in the control group,and the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was 5.13%,which was significantly lower than that in the control group(15.38%),and the difference was statistically significant(P<0.05).ConclusionBudesonide Ultrasonic Atomization combines with Azithromycin in children with Mycoplasma pneumoniae infection,can make the patient′s clinical symptoms,had better clinical curative effect,less adverse reaction,safe and reliable,and is worthy of popularization and application.
|
|
|
|
|
[1] |
黄东明,刘学明,王月玲,等.126例小儿肺炎支原体感染情况及干预措施分析[J].中国妇幼保健,2015,30(21):3622-3624.
|
[2] |
Liu WK,Liu Q,Chen DEH,et al.Epidemiology of acute respiratory infections in children in Guangzhou:a three-year study[J].PloS One,2014,9(5):e96674.
|
[3] |
华志红,宋治军,王伟.阿奇霉素序贯疗法治疗肺炎支原体肺炎[J].中华实用儿科临床杂志,2012,27(4):286-287.
|
[4] |
陈璐,陈艳萍,黄建宝,等.布地奈德联合盐酸氨溴索雾化吸入对小儿肺炎支原体感染所致慢性咳嗽的影响[J].实用临床医药杂志,2014,18(3):66-68,75.
|
[5] |
陆萍,兰常肇,王红,等.阿奇霉素序贯疗法联合布地奈德和可必特雾化吸入治疗小儿支原体肺炎40例[J].中国药业,2013,22(17):92-93.
|
[6] |
程力平,孙捷,柳克智,等.支原体混合感染性患儿肺炎106 例临床分析[J].中国医药导刊,2013,15(1):6-7.
|
[7] |
郑静,宋闻.阿奇霉素联合特布他林和布地奈德治疗小儿支原体肺炎的临床研究[J].中国妇幼保健,2016,31(13):2655-2657.
|
[8] |
卢拥军.雾化吸入布地奈德雾悬浊液治疗小儿喘息性肺炎的疗效分析[J].牡丹江医学院学报,2014,35(2):47-48.
|
[9] |
许全珍.阿奇霉素序贯疗法治疗小儿支原体肺炎临床疗效及安全性研究[J].河北医学,2013,19(1):120-122.
|
[10] |
吴伟波,陈倩.阿奇霉素联合特布他林雾化吸入治疗小儿支原体肺炎的临床疗效[J].中国临床药理学杂志,2014,30(6):3475.
|
[11] |
邓灵东,黄轶喆,刘秀蜀,等.布地奈德联合阿奇霉素治疗儿童肺炎支原体感染的效果观察[J].中国当代医药,2015,8(28):130-132.
|
[12] |
孔卫乾,王金华,崔伟伦,等.布地奈德雾化吸入治疗婴幼儿肺炎支原体感染致慢性咳嗽的疗效[J].中华实用儿科临床杂志,2012,27(4):299-300.
|
[13] |
方炜.布地奈德联合阿奇霉素治疗小儿肺炎支原体感染的临床效果分析[J].中国现代医生,2017,55(4):68-70.
|
[14] |
王素霞,王静,任常军,等.阿奇霉素序贯疗法治疗小儿支原体肺炎的疗效和安全性分析[J].中国生化药物杂志,2014,34(5):133-135.
|
[15] |
李沫民,柳旎,张淼,等.肺炎支原体感染患儿的免疫水平研究[J].中华医院感染学杂志,2017,27(16):3795-3797,3836.
|
[16] |
Shen Y,Zhang J,Hu Y,et al.Combination therapy with immune-modulators andmoxifloxacinon fulminant macrolidere-sistantMycoplasmapneumoniae infection:a case report[J].Pediatr Pulmonol,2013,48(5):519-522.
|
[17] |
陆萍,兰常肇,王红,等.阿奇霉素序贯疗法联合布地奈德和可必特雾化吸入治疗小儿支原体肺炎40例[J].中国药业,2013,22(17):92-93.
|
[18] |
杨立新.红霉素联合阿奇霉素序贯疗法与单用阿奇霉素治疗小儿支原体肺炎的效果比较[J].中国医药导报,2016,13(18):173-176.
|
[19] |
薛红霞,刘连凤,次玲娟,等.布地奈德、异丙托溴铵及干扰素联合雾化吸治疗毛细支气管炎疗效观察[J].现代中西医结合杂志,2016,25(26):2888-2890.
|
[20] |
王新芬.阿奇霉素联合布地奈德混悬液雾化吸入治疗小儿肺炎支原体肺炎 53例疗效观察[J].中国中西医结合儿科学,2014,6(1):55-57.
|
[21] |
吴道勇,李国晖,吕红玲.支原体肺炎胸部多层螺旋CT影像学表现特点分析[J].中国医学装备,2015,12(5):89-91.
|
[22] |
张华俐,王超,张蕊,等.发光免疫分析仪联合检测超敏C反应蛋白、降钙素原及免疫功能对小儿肺炎诊断的价值[J].中国医学装备,2016,13(12):109-112.
|
|
|
|